Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,692 | -15,492 | -9,077 | -4,543 | -26,868 |
| Depreciation Amortization | 323 | 163 | 55 | 6 | 23 |
| Accounts receivable | 285 | 212 | 117 | 169 | -36 |
| Accounts payable and accrued liabilities | -1,342 | -2,891 | -2,979 | -1,252 | 3,354 |
| Other Working Capital | 3,542 | -3,596 | -3,648 | -2,646 | 3,862 |
| Other Operating Activity | 5,078 | 5,004 | 3,352 | 1,284 | -2,926 |
| Operating Cash Flow | $-22,807 | $-16,601 | $-12,180 | $-6,983 | $-22,591 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -8 | -8 | -3 | -33 |
| Purchase Of Investment | -103,602 | -92,273 | -72,445 | N/A | N/A |
| Sale Of Investment | 36,879 | 26,995 | 25,000 | N/A | 1,500 |
| Investing Cash Flow | $-66,734 | $-65,287 | $-47,453 | $-3 | $1,467 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 100 |
| Common Stock Issued | 116,464 | 116,400 | 116,371 | 116,191 | 44,285 |
| Other Financing Activity | -749 | -749 | -749 | -738 | -3,755 |
| Financing Cash Flow | $115,716 | $115,652 | $115,623 | $115,453 | $40,630 |
| Beginning Cash Position | 35,151 | 35,151 | 35,151 | 35,151 | 15,646 |
| End Cash Position | 61,325 | 68,915 | 91,140 | 143,618 | 35,151 |
| Net Cash Flow | $26,174 | $33,764 | $55,989 | $108,467 | $19,505 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,807 | -16,601 | -12,180 | -6,983 | -22,591 |
| Capital Expenditure | -12 | -8 | -8 | -3 | -33 |
| Free Cash Flow | -22,819 | -16,609 | -12,189 | -6,986 | -22,625 |